65 related articles for article (PubMed ID: 8721226)
1. Effect of growth hormone administration on serum somatomedin-C levels in bilharzial and liver disorders patients.
Ahmed SA
J Egypt Soc Parasitol; 1996 Apr; 26(1):27-37. PubMed ID: 8721226
[TBL] [Abstract][Full Text] [Related]
2. Serum growth hormone and somatomedin-C in patients with bilharzial hepatic fibrosis and post hepatitic cirrhosis.
el-Hawy AM; el-Nasr MS; Mahgob MA; Mostafa N
J Egypt Soc Parasitol; 1991 Apr; 21(1):135-44. PubMed ID: 2033287
[TBL] [Abstract][Full Text] [Related]
3. Correlation between the level of serum growth hormone; somatomedin-C; anthropometric measurements and the liver functions in chronic liver diseases.
el-Hawy AM; Seif el-Nasr MS; Mahgoub MA; Mostafa N
J Egypt Soc Parasitol; 1991 Apr; 21(1):229-42. PubMed ID: 2033295
[TBL] [Abstract][Full Text] [Related]
4. Plasma insulin; insulin resistance and glucose intolerance in children with bilharzial hepatic fibrosis.
Zaki K; Kantoosh M; Hamam MA; Shoheib S; Mikhail N; Nour H; Zaki F
Hepatogastroenterology; 1980 Dec; 27(6):417-22. PubMed ID: 7009363
[TBL] [Abstract][Full Text] [Related]
5. Possible contribution of serum activin A and IGF-1 in the development of hepatocellular carcinoma in Egyptian patients suffering from combined hepatitis C virus infection and hepatic schistosomiasis.
Elsammak MY; Amin GM; Khalil GM; Ragab WS; Abaza MM
Clin Biochem; 2006 Jun; 39(6):623-9. PubMed ID: 16624274
[TBL] [Abstract][Full Text] [Related]
6. Circulating markers of oxidative stress and liver fibrosis in Sudanese subjects at risk of schistosomiasis and hepatitis.
Eboumbou C; Steghens JP; Abdallahi OM; Mirghani A; Gallian P; van Kappel A; Qurashi A; Gharib B; De Reggi M
Acta Trop; 2005 May; 94(2):99-106. PubMed ID: 15814296
[TBL] [Abstract][Full Text] [Related]
7. Serum leptin and IGF-I during growth hormone treatment in chronic renal failure.
Patel L; Webb NJ; Bradbury MG; Zaman N; Smith P; Lewis MA; Postlethwaite RJ; Price DA; Clayton PE
Pediatr Nephrol; 2002 Aug; 17(8):643-7. PubMed ID: 12185474
[TBL] [Abstract][Full Text] [Related]
8. Fatty acid composition of serum lipids in bilharzial hepatic fibrosis and chronic active hepatitis.
Gabr Y; Mahfouz M; Mohammed YS
Acta Biol Med Ger; 1975; 34(1):45-51. PubMed ID: 1179920
[TBL] [Abstract][Full Text] [Related]
9. Serum phospholipids in bilharzial hepatic fibrosis and chronic active hepatitis.
Gabr Y; Mahfouz M
Acta Biol Med Ger; 1975; 34(11-12):1827-33. PubMed ID: 788418
[TBL] [Abstract][Full Text] [Related]
10. Dysfunction of the hypothalamic-pituitary-glandular axes and relation to Child-Pugh classification in male patients with alcoholic and virus-related cirrhosis.
Zietz B; Lock G; Plach B; Drobnik W; Grossmann J; Schölmerich J; Straub RH
Eur J Gastroenterol Hepatol; 2003 May; 15(5):495-501. PubMed ID: 12702906
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone/insulin-like growth factor 1 axis recovery after liver transplantation: a preliminary prospective study.
Bassanello M; De Palo EF; Lancerin F; Vitale A; Gatti R; Montin U; Ciarleglio FA; Senzolo M; Burra P; Brolese A; Zanus G; D'Amico DF; Cillo U
Liver Transpl; 2004 May; 10(5):692-8. PubMed ID: 15108263
[TBL] [Abstract][Full Text] [Related]
12. Serum concentrations of insulin-like growth factor-I (IGF-I) in patients with liver cirrhosis.
Vyzantiadis T; Theodoridou S; Giouleme O; Harsoulis P; Evgenidis N; Vyzantiadis A
Hepatogastroenterology; 2003; 50(51):814-6. PubMed ID: 12828091
[TBL] [Abstract][Full Text] [Related]
13. Resistance to growth hormone in children with chronic liver disease.
Bucuvalas JC; Horn JA; Chernausek SD
Pediatr Transplant; 1997 Aug; 1(1):73-9. PubMed ID: 10084790
[TBL] [Abstract][Full Text] [Related]
14. Abnormal growth hormone dynamics in chronic liver disease do not depend on severe parenchymal disease.
Assaad SN; Cunningham GR; Samaan NA
Metabolism; 1990 Apr; 39(4):349-56. PubMed ID: 2182971
[TBL] [Abstract][Full Text] [Related]
15. [Growth factors in assessing hepatic fibrosis in patients with chronic hepatitis C].
Ivkova AN; Il'chenko LIu; Kushlinskiĭ NE; Petrenko NV; Storozhakov GI
Eksp Klin Gastroenterol; 2008; (5):42-6. PubMed ID: 19145916
[No Abstract] [Full Text] [Related]
16. The insulin-like growth factor and binding protein axis in children with end-stage liver disease before and after orthotopic liver transplantation.
Holt RI; Baker AJ; Jones JS; Miell JP
Pediatr Transplant; 1998 Feb; 2(1):76-84. PubMed ID: 10084765
[TBL] [Abstract][Full Text] [Related]
17. Alpha-fetoprotein in adult normals, bilharzial hepatic fibrosis and viral hepatitis in Egypt.
El-Haieg MO; Ibrahim II; Zanaty MF
J Egypt Med Assoc; 1977; 60(9-12):699-706. PubMed ID: 89127
[No Abstract] [Full Text] [Related]
18. Plasma growth hormone-binding protein activity, insulin-like growth factor I, and its binding protein levels in patients with Turner's syndrome: effect of short- and long-term recombinant human growth hormone administration.
Saggese G; Federico G; Cinquanta L
Pediatr Res; 1995 Jan; 37(1):106-11. PubMed ID: 7535419
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of human granulopoiesis in vitro by biosynthetic insulin-like growth factor I/somatomedin C and human growth hormone.
Merchav S; Tatarsky I; Hochberg Z
J Clin Invest; 1988 Mar; 81(3):791-7. PubMed ID: 2963830
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte growth factor and acute phase proteins in patients with chronic liver diseases.
Shiota G; Umeki K; Okano J; Kawasaki H
J Med; 1995; 26(5-6):295-308. PubMed ID: 8721905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
